why sullivan university/university of louisville as main knowledge partners for knowledge...
TRANSCRIPT
Why Sullivan University/University of Louisville
asMain Knowledge Partners
forKnowledge City/University for Seamless
Learning and Research (USER)
You Know of Sullivan University
Capabilities
Expertise
Ability to Respond
Vision
Management
About the University of Louisville
Fastest growing university inNIH support
Growth built on solid strategic/business models
Community (Boyle Report)
State (Postsecondary Education Improvement Act)
Partnership (LMCDC – NUCLEUS)
Our Research Focus
Healthcare/Life Science Hearts Cancer Pediatrics
Birth Defects Ophthalmology Transplantation Neurosciences Homeland Security Infectious Diseases
Our Research Focus
Bioengineering
Logistics/Distribution Management/Systems
Entrepreneurship
Early Childhood/Brain Development
Our Research Emphasis
Translational Research
Creating Knowledge
Improve Quality of Life
Commercialization
Identify & Evaluate•LDG Sleep Therapeutics -Agreed to Partner 5/06•Orthopedic Products -Progress toward Partnership•Medical Imaging Products -Early stages of evaluation
Stage I: Create the Business
•BioInformatics/e-commerce - Progress toward incorporation•ImmunoTheragnostics - Agree to partner 5/06•ULSD Diagnostic/Therapeutic - Agreed to partnership and developed business model•Cardiovascular Device - Conceptual framework in development
Stage II:Prepare for Seed Funding •EndoProtech, Inc. - Received KSTC R&D Voucher Funding•InnoRem, Inc. - KSTC R&D Voucher InitiatedAllTranz, LLC - Partnership Formed•AsotaBio, Inc.*•Inflamed Inc.*
Stage III:Prime for A Round Investment
•Pradama Inc. - Raised $450K in seed funding•RhinoCyte, Inc. - Closing on $460K seed financing •Software Solutions Group Inc. - Securing significant venture capital financing•Ocular Transplantation LLC - Identifying strategic partners•Mindstreet, LLC - Proposal for partnership submitted
•3DR, Inc.•ApoImmune Inc.•Laboratory Partners, Inc.**•PGX Labs
*InflaMed, AsotaBio (founders have moved)**Funding in Place
Origination Launch
Compellingopportunity
Stage I Stage II
Begin seed fundingprocess
Prospecting
Approx. 4months
Approx. 4months
A Round
Possibleelimination point
IND510(k)
Seed Round
Possibleelimination point
Pre-clinical
Stage III
Approx. 12 months
MetaCyte begins the company creationprocess again with a new concept
Clinical*
U of L at a Glance
More than 205 majors, degree and certificate programs
13 academic and professional colleges
Enrollment totaled 21,760 (Fall 2005)
Chronicle of Higher Education cited U of L as fastest growing of Top 100 Institutions in NIH funding
Challenge for Excellence
Enhance education
Grow research
Promote partnerships
Be accountable
Encourage diversity
U of L’s Strategic Goals